Summit Therapeutics Inc. SMMT
16.86 USD -0.97 (-5.47%)
Nov 11, 2026, 2:42 PM EST
16.59 Day range 17.91
12.07 52-week range 29.23
- YTD
- -3.63%
- 1 year
- -12.03%
Financial health
Altman Z-Score
40.67 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1